ID
14653
Beschrijving
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00841113
Link
https://clinicaltrials.gov/show/NCT00841113
Trefwoorden
Versies (1)
- 25-04-16 25-04-16 -
Geüploaded op
25 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT00841113
Eligibility Prostate Cancer NCT00841113
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Hormone therapy and chemotherapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0279025
- UMLS CUI [2]
- C0392920
Beschrijving
Cancer complication
Datatype
boolean
Alias
- UMLS CUI [1]
- C0596237
Beschrijving
Further malignancy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0006826
- UMLS CUI [1,2]
- C0332196
- UMLS CUI [1,3]
- C0007114
Beschrijving
Allergies
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C1518041
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C1268855
Beschrijving
Coagulation disorder
Datatype
boolean
Alias
- UMLS CUI [1]
- C0005779
Beschrijving
Pagets disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0029401
Beschrijving
QTcB
Datatype
boolean
Alias
- UMLS CUI [1]
- C1882512
Similar models
Eligibility Prostate Cancer NCT00841113
- StudyEvent: Eligibility
C0332155 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C1518041 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1268855 (UMLS CUI [2,2])